NCT03755752View on ClinicalTrials.gov

Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

July 25, 2018

Study Completion Date

August 31, 2018

Conditions
Cataract Diabetic
Interventions
PROCEDURE

Phacoemulsification with and without Trypan Blue capsule staining

Phacoemulsification for patients with diabetic retinopathy having cataract in both eyes. One eye underwent phacoemulsification with trypan blue capsule staining and the other eye underwent phacoemulsification without trypan blue.

Trial Locations (1)

71515

Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03755752 - Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients | Biotech Hunter | Biotech Hunter